RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater ...

ED visits RSV tick know as cases rise among children under 4, signaling the start of respiratory virus season amid limited CDC data.

Increasing respiratory syncytial virus (RSV) vaccination among older adults could prevent up to 1600 deaths and 20,000 ...

The adjusted pooled incidence of RSV among preschool children in primary care settings was 62.8 per 1,000 people in the ...

RSV highlighted as a serious and immediate threat to infants and older adults, raising the need for awareness. Immunization now offers a vital tool to protect those who are at most risk.

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

"ArkBio commences Phase II study of AK0610 for RSV prevention" was originally created and published by Clinical Trials Arena, ...

Sanofi has dropped its respiratory syncytial virus (RSV) vaccine for toddlers after the candidate underperformed in a phase 3 ...

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...